Elevance Health (ELV) financials

Managed Health Care · NYSE · Health Care

$420.07 -0.46% Close Oct 30, 2026 Live

Elevance Health revenue and earnings by year

Elevance Health's revenue was $199 billion in the fiscal year to December 31, 2025, up 12.5% from the year before. Net income was $5.66 billion, 2.8% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 9.9% a year on average.

RevenueNet income
$100B$200B
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue199.1177.0171.3156.6138.6121.9104.292.190.084.9
Revenue growth12.5%3.3%9.4%13.0%13.8%16.9%13.1%2.3%6.1%—
Gross profit29.729.729.726.925.224.920.420.217.818.0
Gross margin14.9%16.8%17.3%17.2%18.2%20.4%19.6%21.9%19.8%21.2%
Operating income8.19.18.78.58.87.16.75.85.05.3
Operating margin4.1%5.1%5.1%5.4%6.4%5.8%6.5%6.3%5.5%6.2%
Net income5.76.06.05.96.24.64.83.83.82.5
Net margin2.8%3.4%3.5%3.8%4.4%3.8%4.6%4.1%4.3%2.9%
Diluted EPS$25.21$25.68$25.22$24.28$24.95$17.91$18.44$14.20$14.36$9.21
Free cash flow3.24.66.87.27.39.75.02.63.42.7

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ELV in Markets.

See also: ELV valuation and P/E history · ELV returns

No forecast, no recommendation. This page describes Elevance Health from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.